Physician profile
Sara Millar
NPI 1194254193
$1,463.32
in general payments reported to CMS, 2019-2025
12 companies · $285 in 2025
The $285 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $65.90 · 2021: $567 · 2022: $18.32 · 2023: $14.20 · 2024: $513 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $505.34 | 2021-2025 | |
| Paratek Pharmaceuticals, INC. | $278.52 | 2021-2025 | Nuzyra |
| Organogenesis INC. | $223.79 | 2023-2025 | Affinity, Via Matrix, Novachor |
| Bioventus LLC | $196.18 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $116.49 | 2021-2025 | Grafix, Grafix Pl, Stravix |
| Tactile Systems Technology INC | $24.29 | 2020 | |
| Genzyme Corporation | $23.75 | 2020 | |
| Integra Lifesciences Corporation | $23.26 | 2021 | |
| Orthofix Medical, INC. | $21.06 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.30 | 2021 | |
| Maruho Medical, INC. | $17.86 | 2020 | |
| Ossio INC | $14.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Millar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.